IL-9 antibody injection suppresses the inflammation in colitis mice

Biochemical and Biophysical Research Communications

Volumn 468, Issue 4, 2015, Pages 921-926

  Yuan, Aping ^a,b   Yang, Hang ^b   Qi, Haili ^b   Cui, Jing ^b   Hua, Wei ^b   Li, Can ^b   Pang, Zhigang ^b   Zheng, Wei ^b   Cui, Guanglin ^b,c  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b ZHENGZHOU UNIVERSITY   (China)

^c NORD UNIVERSITY   (Norway)

Author keywords

IL 9; Inflammation; Th9; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE ANTIBODY; DEXTRAN SULFATE; INTERLEUKIN 9; INTERLEUKIN 9 ANTIBODY; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH9 CELL; ULCERATIVE COLITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; COLITIS; COLON; DRUG EFFECTS; HELPER CELL; IMMUNOLOGY; INJECTION; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CELL LINE; COLITIS; COLON; FEMALE; HUMANS; INJECTIONS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-9; MALE; MICE; MICE, INBRED ICR; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; TREATMENT OUTCOME;

EID: 84949603945     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.057     Document Type: Article

References (33)

1. M. Gersemann, J. Wehkamp, and E.F. Stange Innate immune dysfunction in inflammatory bowel disease J. Intern. Med. 271 2012 421 428
2. M.G. Neuman Immune dysfunction in inflammatory bowel disease Transl. Res. J. Lab. Clin. Med. 149 2007 173 186
3. M. Mokry, S. Middendorp, C.L. Wiegerinck, M. Witte, H. Teunissen, C.A. Meddens, E. Cuppen, H. Clevers, and E.E. Nieuwenhuis Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium Gastroenterology 146 2014 1040 1047
4. M.Z. Cader, and A. Kaser Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation Gut 62 2013 1653 1664
5. M. Niessner, and B.A. Volk Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR) Clin. Exp. Immunol. 101 1995 428 435
6. I. Monteleone, M. Sarra, F. Pallone, and G. Monteleone Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr. Mol. Med. 12 2012 592 597
7. A. Ueno, H. Jijon, R. Chan, K. Ford, C. Hirota, G.G. Kaplan, P.L. Beck, M. Iacucci, M. Fort Gasia, H.W. Barkema, R. Panaccione, and S. Ghosh Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients Inflamm. Bowel Dis. 19 2013 2522 2534
8. F. Caprioli, F. Pallone, and G. Monteleone Th17 immune response in IBD: A new pathogenic mechanism J. Crohn's Colitis 2 2008 291 295
9. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation Cytokine 56 2011 633 640
10. R. Rismo, T. Olsen, G. Cui, I. Christiansen, J. Florholmen, and R. Goll Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis Scand. J. Gastroenterol. 47 2012 538 547
11. R. Rismo, T. Olsen, G. Cui, E.J. Paulssen, I. Christiansen, K. Johnsen, J. Florholmen, and R. Goll Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease Scand. J. Gastroenterol. 48 2013 311 319
12. R. Goswami, and M.H. Kaplan A brief history of IL-9 J. Immunol. 186 2011 3283 3288
13. M.H. Kaplan Th9 cells: differentiation and disease Immunol. Rev. 252 2013 104 115
14. Z. Wiener, A. Falus, and S. Toth IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice Cytokine 26 2004 122 130
15. S. Tete, A. Saggini, G. Maccauro, M. Rosati, F. Conti, E. Cianchetti, D. Tripodi, E. Toniato, M. Fulcheri, V. Salini, A. Caraffa, P. Antinolfi, S. Frydas, F. Pandolfi, P. Conti, G. Potalivo, M. Nicoletti, and T.C. Theoharides Interleukin-9 and mast cells J. Biol. Regul. Homeost. Agents 26 2012 319 326
16. M. Chichlowski, G.S. Westwood, S.N. Abraham, and L.P. Hale Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice PLoS One 5 2010 e12220
17. W. Elyaman, E.M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J.C. Renauld, V.K. Kuchroo, and S.J. Khoury IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells Proc. Natl. Acad. Sci. U. S. A. 106 2009 12885 12890
18. M. Rossi, and A. Bot The Th17 cell population and the immune homeostasis of the gastrointestinal tract Int. Rev. Immunol. 32 2013 471 474
19. K. Gerlach, A.N. McKenzie, M.F. Neurath, and B. Weigmann IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis Tissue Barriers 3 2015 e983777
20. K. Gerlach, Y. Hwang, A. Nikolaev, R. Atreya, H. Dornhoff, S. Steiner, H.A. Lehr, S. Wirtz, M. Vieth, A. Waisman, F. Rosenbauer, A.N. McKenzie, B. Weigmann, and M.F. Neurath TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells Nat. Immunol. 15 2014 676 686
21. E.M. Song, S.A. Jung, J.S. Lee, S.E. Kim, K.N. Shim, H.K. Jung, K. Yoo, and H.Y. Park Benzoxazole derivative B-98 ameliorates dextran sulfate sodium-induced acute murine colitis and the change of T cell profiles in acute murine colitis model Korean J. Gastroenterol. Taehan Sohwagi Hakhoe Chi 62 2013 33 41
22. M. Veldhoen, C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset Nat. Immunol. 9 2008 1341 1346
23. F. Loher, C. Bauer, N. Landauer, K. Schmall, B. Siegmund, H.A. Lehr, M. Dauer, M. Schoenharting, S. Endres, and A. Eigler The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation J. Pharmacol. Exp. Ther. 308 2004 583 590
24. B. Siegmund, F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G.S. Firestein, D. Boyle, H.A. Lehr, F. Loher, G. Hartmann, S. Endres, and A. Eigler Adenosine kinase inhibitor GP515 improves experimental colitis in mice J. Pharmacol. Exp. Ther. 296 2001 99 105
25. H. Laroui, S.A. Ingersoll, H.C. Liu, M.T. Baker, S. Ayyadurai, M.A. Charania, F. Laroui, Y. Yan, S.V. Sitaraman, and D. Merlin Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon PLoS One 7 2012 e32084
26. G. Cui, A. Yuan, B. Vonen, and J. Florholmen Progressive cellular response in the lamina propria of the colorectal adenoma-carcinoma sequence Histopathology 54 2009 550 560
27. G. Cui, A. Yuan, R. Goll, and J. Florholmen IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence Scand. J. Gastroenterol. 47 2012 1304 1312
28. N. Nalleweg, M.T. Chiriac, E. Podstawa, C. Lehmann, T.T. Rau, R. Atreya, E. Krauss, G. Hundorfean, S. Fichtner-Feigl, A. Hartmann, C. Becker, and J. Mudter IL-9 and its receptor are predominantly involved in the pathogenesis of UC Gut 64 2014 743 755
29. S. Fujino, A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 2003 65 70
30. M. Niessner, and B.A. Volk Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: evaluation of an in vitro model Eur. J. Clin. Investig. 25 1995 155 164
31. C. Goranzon, A.K. Kumawat, E. Hultgren-Hornqvist, C. Tysk, S. Eriksson, J. Bohr, and N. Nyhlin Immunohistochemical characterization of lymphocytes in microscopic colitis J. Crohn's Colitis 7 2013 e434 442
32. M.J. Waldner, and M.F. Neurath Colitis-associated cancer: the role of T cells in tumor development Seminars Immunopathol. 31 2009 249 256
33. M. Stassen, E. Schmitt, and T. Bopp From interleukin-9 to T helper 9 cells Ann. N. Y. Acad. Sci. 1247 2012 56 68